|
|
|
|
|
|
|
|
|
|
Super Quote | Detail Quote | Interactive Chart | Transaction | Related News | Related Securities | Company Information | Dividend Records | Short Sell
00954 CHANGMAO BIO
Nominal 
0.400 -0.005 (-1.235%) Profitability Analysis
| 2023/12 | 2022/12 | 2021/12 | 2020/12 | 2019/12 | |
| ROAA (%) | -7.027% | 7.528% | 6.466% | 2.123% | 7.933% |
| ROAE (%) | -12.034% | 11.036% | 8.662% | 2.567% | 9.028% |
| Return on Capital Employed (%) | -9.382% | 8.729% | 8.333% | 2.585% | 8.771% |
Margin Analysis
| 2023/12 | 2022/12 | 2021/12 | 2020/12 | 2019/12 | |
| Gross Profit Margin (%) | 4.051% | 24.770% | 7.059% | 21.492% | 27.327% |
| EBITDA Margin (%) | -1.460% | 16.653% | 20.993% | 11.209% | 19.849% |
| Pre-tax Profit Margin (%) | -9.195% | 12.005% | 15.404% | 3.862% | 12.648% |
| Net Profit Margin (%) | -13.508% | 11.153% | 10.642% | 3.789% | 11.788% |
Liquidity Analysis
| 2023/12 | 2022/12 | 2021/12 | 2020/12 | 2019/12 | |
| Current Ratio (X) | 1.040 X | 1.321 X | 1.235 X | 2.084 X | 4.251 X |
| Quick Ratio (X) | 0.634 X | 0.734 X | 0.756 X | 1.445 X | 2.798 X |
Leverage Analysis
| 2023/12 | 2022/12 | 2021/12 | 2020/12 | 2019/12 | |
| Total Liabilities / Total Assets(%) | 47.558% | 35.456% | 27.076% | 23.298% | 10.224% |
| Total Debt / Total Assets (%) | 39.811% | 24.156% | 9.331% | 0.095% | 2.907% |
| Net Debt / Total Assets (%) | 32.603% | 19.184% | 3.202% | -15.760% | -13.388% |
| Total Debt / Shareholders' Funds (%) | 75.902% | 37.443% | 12.804% | 0.124% | 3.242% |
| Long Term Debt / Shareholders' Funds (%) | 38.589% | 19.688% | 0.254% | 0% | 0.047% |
| Net Debt / Shareholders' Funds (%) | 62.160% | 29.737% | 4.393% | -20.564% | -14.926% |
| Net Cash / (Debt) ($) | (405.091M) | (231.509M) | (30.627M) | 133.538M | 98.767M |
| Net Cash / (Debt) per share ($) | (0.765) | (0.437) | (0.058) | 0.252 | 0.186 |
| Total Debt / Capital Employed (%) | 53.926% | 31.252% | 12.754% | 0.124% | 3.227% |
| Interest Coverage Ratio (X) | N/A | 33.838 X | 44.242 X | 277.645 X | 121.063 X |
Efficiency Analysis
| 2023/12 | 2022/12 | 2021/12 | 2020/12 | 2019/12 | |
| Inventory Turnover (Day) | 87.474 Day | 94.311 Day | 89.027 Day | 121.292 Day | 108.765 Day |
| Receivables Turnover (Day) | 46.796 Day | 40.813 Day | 52.411 Day | 54.928 Day | 60.074 Day |
| Payables Turnover (Day) | 27.876 Day | 40.584 Day | 58.120 Day | 40.620 Day | 14.730 Day |
| Remarks: | Real time quote last updated: 27/12/2024 15:27 |
| Real-time basic market prices of Hong Kong securities are provided by HKEx; a Designated Website authorized by the HKEx Group to provide the Service | |
| Profit / (Loss) Attributable to Shareholders (¥) | RMB -18,786,000 |
| %Change | -- |
| EPS / (LPS) | RMB -0.035 |
| NBV Per Share (¥) | RMB 1.195 |